Agmatine acts on at least four receptor systems simultaneously: it blocks NMDA glutamate receptors (reducing excitotoxicity and pain), activates imidazoline receptors (lowering blood pressure and modulating insulin), stimulates alpha-2 adrenergic receptors (pain modulation), and inhibits nitric oxide synthase (NOS) — but selectively. It inhibits iNOS (inflammatory NO) while preserving eNOS (vascular NO), which is why it can reduce inflammation without impairing blood flow.
Independently graded against 173,636 indexed supplements with 177 published clinical interactions, sourced from PubMed, FDA CAERS, openFDA, and NIH DSLD | Last updated:
Not medical advice. Based on published clinical research and systematic reviews.